Hepatitis E virus persists in the presence of a type III interferon response

PLoS Pathogens

Volumn 13, Issue 5, 2017, Pages

  Yin, Xin ^a   Li, Xinlei ^a   Ambardekar, Charuta ^a   Hu, Zhimin ^a   Lhomme, Sébastien ^a   Feng, Zongdi ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERFERON REGULATORY FACTOR 3; LUCIFERASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; DEAD BOX PROTEIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HEPEVIRIDAE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MRNA EXPRESSION ASSAY; NONHUMAN; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENDAI VIRUS; STIMULATION; VIRUS REPLICATION; WESTERN BLOTTING; GENETICS; HEPATITIS E; HUMAN; IMMUNOLOGY; LIVER CELL; PHYSIOLOGY; VIROLOGY;

DEAD-BOX RNA HELICASES; HEPATITIS E; HEPATITIS E VIRUS; HEPATOCYTES; HUMANS; INTERFERONS; VIRUS REPLICATION;

EID: 85020206652     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006417     Document Type: Article

References (63)

1. Meng XJ, Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013;33(1):41–9. Epub 2013/04/09. doi: 10.1055/s-0033-1338113 23564388
2. Cao D, Meng XJ, Molecular biology and replication of hepatitis E virus. Emerging microbes & infections. 2012;1(8):e17. Epub 2012/08/01. PubMed Central PMCID: PMC3630916.
3. Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, et al. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology. 2014;147(5):1008–11.e7; quiz e15-6. Epub 2014/09/03. doi: 10.1053/j.gastro.2014.08.040 25181691
4. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A. 2008;105(19):7034–9. Epub 2008/05/10. PubMed Central PMCID: PMC2383932. doi: 10.1073/pnas.0707882105 18467494
5. Sheahan T, Imanaka N, Marukian S, Dorner M, Liu P, Ploss A, et al. Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness. Cell Host & Microbe. 2014;15(2):190–202.
6. Lanford RE, Feng Z, Chavez D, Guerra B, Brasky KM, Zhou Y, et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A. 2011;108(27):11223–8. doi: 10.1073/pnas.1101939108 21690403
7. Walker CM, Feng Z, Lemon SM, Reassessing immune control of hepatitis A virus. Current opinion in virology. 2015;11:7–13. Epub 2015/01/27. PubMed Central PMCID: PMCPMC4456347. doi: 10.1016/j.coviro.2015.01.003 25617494
8. Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C, et al. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 2016. Epub 2016/03/24.
9. Moal V, Textoris J, Ben Amara A, Mehraj V, Berland Y, Colson P, et al. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. The Journal of infectious diseases. 2013;207(1):125–32. Epub 2012/10/18. doi: 10.1093/infdis/jis632 23072754
10. Yu C, Boon D, McDonald SL, Myers TG, Tomioka K, Nguyen H, et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol. 2010;84(21):11264–78. Epub 2010/08/27. PubMed Central PMCID: PMC2953165. doi: 10.1128/JVI.01205-10 20739520
11. Wang W, Xu L, Brandsma JH, Wang Y, Hakim MS, Zhou X, et al. Convergent Transcription of Interferon-stimulated Genes by TNF-alpha and IFN-alpha Augments Antiviral Activity against HCV and HEV. Scientific reports. 2016;6:25482. Epub 2016/05/07. PubMed Central PMCID: PMCPMC4858707. doi: 10.1038/srep25482 27150018
12. Todt D, Francois C, Anggakusuma Behrendt P, Engelmann M, Knegendorf L, et al. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication. Antimicrobial agents and chemotherapy. 2016;60(4):2132–9. Epub 2016/01/21. PubMed Central PMCID: PMCPmc4808167. doi: 10.1128/AAC.02427-15 26787701
13. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A. 2007;104(17):7253–8. doi: 10.1073/pnas.0611506104 17438296
14. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A. 2006;103(15):6001–6. Epub 2006/04/06. PubMed Central PMCID: PMCPmc1458687. doi: 10.1073/pnas.0601523103 16585524
15. Hirai-Yuki A, Hensley L, McGivern DR, Gonzalez-Lopez O, Das A, Feng H, et al. MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science. 2016. Epub 2016/09/17.
16. Emerson SU, Purcell RH, Hepatitis E virus. Rev Med Virol. 2003;13(3):145–54. Epub 2003/05/13. doi: 10.1002/rmv.384 12740830
17. Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J, Hepatitis E Pathogenesis. Viruses. 2016;8(8). Epub 2016/08/17. PubMed Central PMCID: PMCPMC4997574.
18. Yin X, Li X, Feng Z, Role of Envelopment in the HEV Life Cycle. Viruses. 2016;8(8). Epub 2016/08/23. PubMed Central PMCID: PMCPMC4997591.
19. Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ, Hepatitis E virus inhibits type I interferon induction by ORF1 products. J Virol. 2014;88(20):11924–32. Epub 2014/08/08. PubMed Central PMCID: PMCPmc4178743. doi: 10.1128/JVI.01935-14 25100852
20. Nan Y, Ma Z, Wang R, Yu Y, Kannan H, Fredericksen B, et al. Enhancement of interferon induction by ORF3 product of hepatitis E virus. J Virol. 2014;88(15):8696–705. Epub 2014/05/23. PubMed Central PMCID: PMCPmc4135948. doi: 10.1128/JVI.01228-14 24850742
21. Zhang F, Qi Y, Harrison TJ, Luo B, Zhou Y, Li X, et al. Hepatitis E genotype 4 virus from feces of monkeys infected experimentally can be cultured in PLC/PRF/5 cells and upregulate host interferon-inducible genes. J Med Virol. 2014;86(10):1736–44. Epub 2014/07/22. doi: 10.1002/jmv.24014 25042677
22. Devhare PB, Chatterjee SN, Arankalle VA, Lole KS, Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus. PLoS ONE. 2013;8(5):e63793. doi: 10.1371/journal.pone.0063793 23671700
23. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A. 2011;108(6):2438–43. Epub 2011/01/26. PubMed Central PMCID: PMC3038723. doi: 10.1073/pnas.1018878108 21262830
24. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature genetics. 2013;45(2):164–71. Epub 2013/01/08. PubMed Central PMCID: PMCPMC3793390. doi: 10.1038/ng.2521 23291588
25. Graff J, Torian U, Nguyen H, Emerson SU, A Bicistronic Subgenomic mRNA Encodes both the ORF2 and ORF3 Proteins of Hepatitis E Virus. Journal of Virology. 2006;80(12):5919–26. doi: 10.1128/JVI.00046-06 16731930
26. Österlund PI, Pietilä TE, Veckman V, Kotenko SV, Julkunen I, IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-λ) Genes. The Journal of Immunology. 2007;179(6):3434–42. 17785777
27. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ, MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell. 2011;146(3):448–61. Epub 2011/07/26. PubMed Central PMCID: PMCPMC3179916. doi: 10.1016/j.cell.2011.06.041 21782231
28. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr.Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008;454(7203):523–7. Epub 2008/06/13. PubMed Central PMCID: PMCPMC2856441. doi: 10.1038/nature07106 18548002
29. Wack A, Terczynska-Dyla E, Hartmann R, Guarding the frontiers: the biology of type III interferons. Nature immunology. 2015;16(8):802–9. Epub 2015/07/22. doi: 10.1038/ni.3212 26194286
30. Wen Z, Zhong Z, Darnell JE, Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82(2):241–50. 7543024
31. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Müller M, et al. Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-γ-Dependent Innate Immunity. Immunity. 2003;19(6):793–802. 14670297
32. Panda SK, Ansari IH, Durgapal H, Agrawal S, Jameel S, The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol. 2000;74(5):2430–7. Epub 2000/02/09. PubMed Central PMCID: PMCPMC111726. 10666275
33. Ropp SL, Tam AW, Beames B, Purdy M, Frey TK, Expression of the hepatitis E virus ORF1. Arch Virol. 2000;145(7):1321–37. Epub 2000/08/30. 10963340
34. Sehgal D, Thomas S, Chakraborty M, Jameel S, Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virology journal. 2006;3:38. Epub 2006/05/27. PubMed Central PMCID: PMCPMC1481634. doi: 10.1186/1743-422X-3-38 16725054
35. Perttila J, Spuul P, Ahola T, Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1. J Gen Virol. 2013;94(Pt 4):807–16. doi: 10.1099/vir.0.049577-0 23255617
36. Suppiah S, Zhou Y, Frey TK, Lack of processing of the expressed ORF1 gene product of hepatitis E virus. Virology journal. 2011;8:245. Epub 2011/05/21. PubMed Central PMCID: PMCPMC3116494. doi: 10.1186/1743-422X-8-245 21595991
37. Israelow B, Narbus CM, Sourisseau M, Evans MJ, HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection. Hepatology. 2014;60(4):1170–9. Epub 2014/05/17. PubMed Central PMCID: PMC4176518. doi: 10.1002/hep.27227 24833036
38. Park H, Serti E, Eke O, Muchmore B, Prokunina-Olsson L, Capone S, et al. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology. 2012;56(6):2060–70. Epub 2012/06/19. PubMed Central PMCID: PMC3581145. doi: 10.1002/hep.25897 22706965
39. Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, et al. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology. 2011;54(6):1913–23. Epub 2011/07/30. PubMed Central PMCID: PMC3219820. doi: 10.1002/hep.24580 21800339
40. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology. 2012;142(4):978–88. Epub 2012/01/18. PubMed Central PMCID: PMCPmc3435150. doi: 10.1053/j.gastro.2011.12.055 22248663
41. Lee HC, Narayanan S, Park SJ, Seong SY, Hahn YS, Transcriptional regulation of IFN-lambda genes in hepatitis C virus-infected hepatocytes via IRF-3.IRF-7.NF-kappaB complex. The Journal of biological chemistry. 2014;289(8):5310–9. Epub 2014/01/05. PubMed Central PMCID: PMC3931086. doi: 10.1074/jbc.M113.536102 24385435
42. Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity. 2015;42(1):123–32. Epub 2015/01/06. doi: 10.1016/j.immuni.2014.12.016 25557055
43. Balagopal A, Thomas DL, Thio CL, IL28B and the control of hepatitis C virus infection. Gastroenterology. 2010;139(6):1865–76. Epub 2010/10/19. PubMed Central PMCID: PMCPMC3072961. doi: 10.1053/j.gastro.2010.10.004 20950615
44. Feng Z, Li Y, McKnight KL, Hensley L, Lanford RE, Walker CM, et al. Human pDCs preferentially sense enveloped hepatitis A virions. The Journal of clinical investigation. 2015;125(1):169–76. PubMed Central PMCID: PMC4382264. doi: 10.1172/JCI77527 25415438
45. Waggoner SN, Reighard SD, Gyurova IE, Cranert SA, Mahl SE, Karmele EP, et al. Roles of natural killer cells in antiviral immunity. Current opinion in virology. 2016;16:15–23. Epub 2015/11/23. PubMed Central PMCID: PMCPMC4821726. doi: 10.1016/j.coviro.2015.10.008 26590692
46. Randall G, Chen L, Panis M, Fischer AK, Lindenbach BD, Sun J, et al. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology. 2006;131(5):1584–91. Epub 2006/11/15. doi: 10.1053/j.gastro.2006.08.043 17101330
47. Schneider WM, Chevillotte MD, Rice CM, Interferon-stimulated genes: a complex web of host defenses. Annual review of immunology. 2014;32:513–45. Epub 2014/02/22. PubMed Central PMCID: PMCPMC4313732. doi: 10.1146/annurev-immunol-032713-120231 24555472
48. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–5. Epub 2011/04/12. PubMed Central PMCID: PMCPMC3409588. doi: 10.1038/nature09907 21478870
49. Garaigorta U, Chisari FV, Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell host & microbe. 2009;6(6):513–22. Epub 2009/12/17. PubMed Central PMCID: PMCPMC2905238.
50. Katsounas A, Hubbard JJ, Wang CH, Zhang X, Dou D, Shivakumar B, et al. High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV. Journal of medical virology. 2013;85(6):959–63. Epub 2013/04/17. doi: 10.1002/jmv.23576 23588721
51. Feng Z, Li Y, McKnight KL, Hensley L, Lanford RE, Walker CM, et al. Human pDCs preferentially sense enveloped hepatitis A virions. The Journal of clinical investigation. 2014. Epub 2014/11/22.
52. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A. 2010;107(16):7431–6. Epub 2010/03/17. PubMed Central PMCID: PMCPMC2867703. doi: 10.1073/pnas.1002301107 20231459
53. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM, Gale M, Jr.Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology. 2008;47(3):799–809. Epub 2008/01/19. doi: 10.1002/hep.22076 18203148
54. Shukla P, Nguyen HT, Faulk K, Mather K, Torian U, Engle RE, et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol. 2012;86(10):5697–707. Epub 2012/03/09. PubMed Central PMCID: PMC3347312. doi: 10.1128/JVI.00146-12 22398290
55. Graff J, Torian U, Nguyen H, Emerson SU, A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. Journal of virology. 2006;80(12):5919–26. Epub 2006/05/30. PubMed Central PMCID: PMC1472559. doi: 10.1128/JVI.00046-06 16731930
56. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(6):2438–43. Epub 2011/01/26. PubMed Central PMCID: PMC3038723. doi: 10.1073/pnas.1018878108 21262830
57. Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, et al. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia. 2011;59(1):58–67. PubMed Central PMCID: PMC3082435. doi: 10.1002/glia.21076 20878770
58. Bender S, Reuter A, Eberle F, Einhorn E, Binder M, Bartenschlager R, Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus. PLoS pathogens. 2015;11(11):e1005264. Epub 2015/11/21. PubMed Central PMCID: PMCPMC4654527. doi: 10.1371/journal.ppat.1005264 26588843
59. Noureddin M, Rotman Y, Zhang F, Park H, Rehermann B, Thomas E, et al. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study. Genes and immunity. 2015;16(5):321–9. Epub 2015/05/29. doi: 10.1038/gene.2015.11 26020282
60. Dansako H, Yamane D, Welsch C, McGivern DR, Hu F, Kato N, et al. Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cells. PLoS pathogens. 2013;9(5):e1003345. PubMed Central PMCID: PMC3662657. doi: 10.1371/journal.ppat.1003345 23717201
61. Li L, Lei QS, Zhang SJ, Kong LN, Qin B, Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling. PloS one. 2016;11(5):e0156496. Epub 2016/05/27. PubMed Central PMCID: PMCPMC4882066. doi: 10.1371/journal.pone.0156496 27227879
62. Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262 11846609
63. Yin X, Ambardekar C, Lu Y, Feng Z, Distinct entry mechanisms for non-enveloped and quasi-enveloped hepatitis E virus. J Virol. 2016. Epub 2016/02/13.